Gestational diabetes mellitus and COVID-19, clinical characteristics and review of the literature

• Published in: Primary care diabetes Vol. 15; no. 5; pp. 887 - 889
• Main Authors: Violante-Cumpa, Jorge R., Lavalle-González, Fernando J., Mancillas-Adame, Leonardo G., Ávila-Hipólito, Edmundo D., Violante-Cumpa, Karla A.
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.10.2021; Primary Care Diabetes Europe. Published by Elsevier Ltd
• Subjects: Brief Report; Complications; COVID-19; Gestational diabetes mellitus; Obesity; Pregnancy; SARS-CoV-2; COVID-19; Pregnancy; Gestational diabetes mellitus; Obesity; SARS-CoV-2; Complications
• ISSN: 1751-9918; 1878-0210; 1878-0210
• DOI: 10.1016/j.pcd.2021.07.016

•GDM prevalence in women with COVID-19 is approximately 7.5–11.6%.•Cough was the most common clinical presentation of COVID-19 among women with GDM.•Maternal prognosis depends on mother’s age, comorbidities and severity of COVID-19.•Newborn prognosis is usually good but highly depends on maternal complications. There is a lack of information about the maternal-fetal outcomes in patients with gestational diabetes and concomitant COVID-19; and there is even less information about the outcomes of pregnant women with gestational diabetes and COVID-19. We present a case of a primigravidae of 20-year-old woman with gestational diabetes and COVID-19 and a review of the literature.